Mealey's (January 29, 2016, 10:46 AM EST) -- CAMDEN, N.J. — The New Jersey federal judge overseeing the Benicar multidistrict litigation on Jan. 21 denied a defense request to seal three adverse event reports and told the maker of the drug to justify sealing six other documents consisting of emails and reports about the drug’s side effects (In Re: Benicar [Olmesartan] Products Liability Litigation, MDL Docket No. 15-2606, D. N.J.; 2016 U.S. Dist. LEXIS 7977)....